Pfizer vaccines for 5-11 year-olds may be coming soon

Pfizer/BioNTech, the maker of one of the COVID-19 vaccines, announced that their trial on children ages 5-11 is safe and that the vaccine generated antibodies to the virus. They are expected to submit to the US FDA for emergency use.

Over 2,000 children were given smaller doses (10 versus 30 micrograms) in the trial. Since school has resumed this year, there have been more cases of COVID-19 among children.

According to CNN, more than 28 million additional people will be eligible for the COVID-19 vaccine if the Pfizer vaccine for 5-11 year-olds is approved.

About Momo Chang

Momo Chang is a freelance journalist based in the San Francisco Bay Area. She is the Oakland Voices Alumni Coordinator. Her work focuses on healthcare, immigration, education, Asian American communities, food and culture. She is a former staff writer at the Oakland Tribune. Momo has received journalism awards from the Society of Professional Journalists for investigative reporting and the Asian American Journalists Association, among others. Her work has appeared in the East Bay Express, San Francisco Chronicle, Wired, and The New York Times. Momo is primarily a print journalist who also produces audio and visual stories for documentary film and radio. She is a Senior Contributing Editor for Hyphen and formerly the Content Manager at the Center for Asian American Media (CAAM). View all posts by Momo Chang →

Post a comment

Your email is never shared. Required fields are marked *

*
*